Cost savings associated with smoking cessation for low-income pregnant women

Nicole Thorsen1, Lisette Khalil

  • 1Wisconsin Women's Health Foundation, WI 53713, USA.

Despite the many health risks associated with smoking during pregnancy, it remains a chief public health concern with a high prevalence evident at the local level. In Wisconsin, the First Breath program was developed to help pregnant smokers quit and served 424 women during its pilot phase in 2001 and 2002. This cost savings analysis included claims associated with First Breath enrollees who were identified within the Wisconsin Medicaid data warehouse. This analysis allowed for a comparison of medical claims for women who quit smoking through the First Breath program versus those who continued to smoke. Three billing categories were included in this analysis: mother's maternity admissions (maternal DRG), inpatient neonatal care (neonate DRG), and infant's medical costs for the first 6 months of life. Average Medicaid savings per First Breath enrollee who quit smoking was 1274 dollars. Applying this savings to the actual number of women who quit smoking during the pilot study gives a total savings of 137,592 dollars for the Medicaid program. Considering the maximum Medicaid cost of providing cessation services to all First Breath participants, the return on investment associated with the First Breath program is 9 to 1.

Related Concept Videos

Stress Prevention and Stress Management Techniques IV01:26

Stress Prevention and Stress Management Techniques IV

Stress often leads to unhealthy habits like smoking, excessive drinking, and overeating, which offer short-term relief but ultimately increase long-term health risks. These behaviors create a cycle that temporarily lowers stress levels but can result in severe long-term health consequences. Breaking these habits is essential to reduce the risk of chronic diseases and improve overall well-being. Three primary changes that support better health include quitting smoking, reducing alcohol intake,...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Lifestyle Factors and Health01:20

Lifestyle Factors and Health

Lifestyle factors play a critical role in maintaining overall health and preventing chronic diseases. Key elements, such as regular physical activity, a nutritious diet, and abstinence from smoking, can significantly enhance physical, mental, and emotional well-being while reducing the risk of several life-threatening conditions.
Benefits of Physical Activity
Physical activity, whether through structured exercise or casual activities like walking, biking, or dancing, is a cornerstone of a...
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...